Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Translated Tool from NCCN Measures Mental Health "Temperature" of People with Cancer

PLYMOUTH MEETING, Pennsylvania, July 13, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)--an alliance of leading cancer centers in the United States--today announced the NCCN Distress Thermometer has been translated into46 languages. This free resource helps providers worl...

2020-07-13 08:05 2816

Translated Tool from NCCN Measures Mental Health

Mallinckrodt and Terumo BCT Announce Positive Recommendations for Public Funding of UVADEX® (methoxsalen) for ECP Administration with the THERAKOS® CELLEX® Photopheresis System for Treatment of Cutaneous T-Cell Lymphoma (CTCL) in Adults

– In a rare dual-review process, two independent advisory committees to the Australian Minister for Health recommend reimbursement based on a favorable clinical and cost-effectiveness comparison – STAINES-UPON-THAMES, United Kingdom and LAKEWOOD, Colorado, July 13, 2020 /PRNewswire/ -- Mallinckr...

2020-07-13 06:00 6702

Antengene Appoints Former Celgene ANZ Medical Leader Dirk Hoenemann as Head of Medical Affairs in Asia Pacific Region & Early Clinical Development

SHANGHAI and MELBOURNE, Australia, July 13, 2020 /PRNewswire/ -- Antengene Corporation (Antengene) today announced the appointment ofDirk Hoenemann, M.D as VP, Head of Medical Affairs for Asia Pacific Region (APAC) and Early Clinical Development. He will report directly to Mr.Thomas Karalis, Head...

2020-07-13 06:00 4621

Antengene Appoints Former Celgene ANZ Medical Leader Dirk Hoenemann as Head of Medical Affairs in Asia Pacific Region & Early Clinical Development

Samsung Biologics signs additional development and manufacturing agreement with STCube

SONGDO, South Korea, July 11, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has further expanded its partnership with STCube through an additional development and manufacturing service agreement of STM418, an anti-PD1 immuno-oncology candidate. STM418 received much attention from the biopha...

2020-07-12 08:00 1777

United Imaging Announces New Technology That Advances Molecular Imaging, Hints at a Series of New Announcements

HOUSTON, July 11, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, continues to set a new standard in molecular imaging and redefine nuclear medicine. The company has begun unveiling new technology that showcases more of its all-digital ...

2020-07-11 20:00 1805

World's First FDA IDE Coronary Patient Treated With a DEB

NYON, Switzerland, July 11, 2020 /PRNewswire/ -- MedAlliance has announced enrollment of the first patient in its study ofSELUTION SLR™ 014 DEB for the treatment of In-Stent Restenosis (ISR). This is the first DEB accepted by the FDA for its 'Breakthrough Progr...

2020-07-11 08:00 3373

Ocumension Therapeutics Launches Initial Public Offering on Hong Kong Stock Exchange

SHANGHAI, July 10, 2020 /PRNewswire/ -- Ocumension Therapeutics ("Ocumension"), aChina-based ophthalmic pharmaceutical platform company, has today launched its Initial Public Offering (IPO) of the company's stock on The Stock Exchange of Hong Kong (HKEX). Ocumension plans to offer 105,930,000 shar...

2020-07-10 21:55 20074

CS02 Changes the Landscape of Diabetes Treatment: CenterLab Announces Positive Topline Results of Phase 2 Trial

TAIPEI, July 10, 2020 /PRNewswire/ -- Center Laboratories Inc. (CenterLab: 4123.TWO), a pharmaceutical company dedicated in specialty drug product development, announced today that the anti-diabetic drug – CS02 meets its primary endpoint. The topline results of a phase 2 clinical trial of CS02...

2020-07-10 20:43 4357

Sedana Medical Announces Positive Top Line Result in Pivotal IsoConDa Study

STOCKHOLM, July 10, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a positive top line result for the company's pivotal phase III study, IsoConDa. The study reached its primary endpoint; to show that IsoConDa (isoflurane), administered with AnaConDa, is an ef...

2020-07-10 13:32 1669

Merck Opens its Largest M Lab™ Collaboration Center in Shanghai

-- Focus on improving and optimizing drug discovery, development and manufacturing -- Integrated lab with customizable solutions, validation services, training and hands-on applications -- Shanghai center is newest and largest addition to Merck's global network of nine M Lab™ Collaboration Cente...

2020-07-10 13:00 3488

Merck Opens its Largest M Lab™ Collaboration Center in Shanghai

Carromex Unveils Pharma Leads, a Groundbreaking Cloud-based Platform for Rapid Drug Analysis and Discovery

SYDNEY and MELBOURNE, Australia, July 9, 2020 /PRNewswire/ -- Carromex, a mathematical research-based innovation company based inAustralia, unveiled a new cloud-based pharmaceutical software platform called Pharma Leads https://carromex.com/products/pharma-leads/

2020-07-10 11:31 1247

PolyU discovers the effect of chemical compound PTU on autophagy in zebrafish embryos, sheds light on cancer medication research

HONG KONG, July 10, 2020 /PRNewswire/ -- The zebrafish has been utilised as a model organism for biomedical research globally for half a century, mainly due to the high genetic similarity (over 70%) between zebrafish and human genes, with over 80% of human morbid genes related to at least one zeb...

2020-07-10 10:18 2788

PolyU discovers the effect of chemical compound PTU on autophagy in zebrafish embryos, sheds light on cancer medication research

Q Division Bringing Emerging Technology Expertise to Advanced Materials Pandemic Task Force

DAYTON, Ohio, July 9, 2020 /PRNewswire/ -- Q Division today announced their participation as commercial retail experts in the global Advanced Materials Pandemic Task Force (AMPT) - an international public-interest initiative focused on using Advanced Materials to solve some of humanity's most pre...

2020-07-09 22:00 1966

Q Division Bringing Emerging Technology Expertise to Advanced Materials Pandemic Task Force

Laboratory Studies Confirm BETADINE(R) Antiseptic Products' Effectiveness Against COVID-19 Virus

SINGAPORE, July 9, 2020 /PRNewswire/ -- Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE® antiseptic products against the novel coronavirus (SARS-CoV-2) which causes COVID-19 disease. Testing has demo...

2020-07-09 21:27 4124

WuXi AppTec to Launch a Special Webinar on Collaborations that Transform on July 16 | Advances in Rare Diseases: Hemophilia

SHANGHAI and SAN DIEGO, July 9, 2020 /PRNewswire/ -- WuXi AppTec is pleased to announce that they are about to launch the second session of the webinar series "Collaborations That Transform," highlighting the impact of partnerships in bringing effective therapies to patients. This complimentary w...

2020-07-09 16:32 1594

AGC Biologics Collaborates with Molecular Partners AG to Develop Anti-COVID-19 DARPin® Program

SEATTLE, July 9, 2020 /PRNewswire/ -- Global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO)AGC Biologics is partnering with clinical-stage biotech companyMolecular Partners AG to develop a new class of custom-built protein therapeutics known as DARPin®. AGC Biologics...

2020-07-09 13:00 2824

Innovent Announces First Patient Dosed in a Phase 1b Clinical Trial of Sintilimab plus Surufatinib in Advanced Malignancies in China

SUZHOU, China, July 9, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today anno...

2020-07-09 08:00 12368

Paige Applauded by Frost & Sullivan for its Leading AI-based Computational Pathology Offering that Enables Fast and Accurate Cancer Diagnoses

Paige leveraged the world's largest dataset in pathology to develop an unparalleled computation pathology offering SANTA CLARA, California, July 8, 2020 /PRNewswire/ -- Based on its recent analysis of the North American AI-based digital pathology market, Frost & Sullivan recognizesPaige with the...

2020-07-08 23:40 1779

Paige Applauded by Frost & Sullivan for its Leading AI-based Computational Pathology Offering that Enables Fast and Accurate Cancer Diagnoses

Asieris Received China NMPA's Approval to Start a Global Phase III Clinical Trial for APL-1702 to Treat Cervical Precancerous Lesions (HSIL)

SHANGHAI, July 8, 2020 /PRNewswire/ -- Asieris Pharmaceuticals (Asieris), a China-based biotech company with global aspirations to discover, develop and commercialize innovative drugs for the treatment of genitourinary tumors and related diseases, announced today it has received Clinical Trial Ap...

2020-07-08 22:00 1354

Lipidor Signs Agreement With CRO for Implementation of Phase III Clinical Study of Drug Candidate AKP-02 Against Psoriasis

STOCKHOLM, July 8, 2020 /PRNewswire/ -- Lipidor AB (Nasdaq First North: LIPI) today announced an agreement with Cadila Pharmaceuticals, a leading Indian pharmaceutical company with extensive CRO capacity, to conduct a Phase III study for Lipidor's drug candidate AKP-02. The study is expected to c...

2020-07-08 14:57 1799

1 ... 550 551 552553554 555 556 ... 608